Showing results (1-10 of 1,246) with videos related to
Sort By:
Pageof 125
BMC Neurology|November 27, 2019
Logopenic progressive aphasia with neologisms: a case reportHiroyuki Watanabe, Manabu Ikeda, Etsuro MoriFrontiers in Neurology|March 6, 2020
Primary Progressive Aphasia as a Prodromal State of Dementia With Lewy Bodies: A Case ReportHiroyuki Watanabe, Manabu Ikeda, Etsuro MoriFrontiers in Neurology|July 18, 2020
Non-fluent/Agrammatic Variant of Primary Progressive Aphasia With Generalized Auditory AgnosiaHiroyuki Watanabe, Manabu Ikeda, Etsuro MoriBrain Communications|June 10, 2022
Unclassified fluent variants of primary progressive aphasia: distinction from semantic and logopenic variantsHiroyuki Watanabe, Sakura Hikida, Manabu Ikeda, et al.Frontiers in Neurology|April 20, 2023
Aphasic mild cognitive impairment in prodromal dementia with Lewy bodiesHiroyuki Watanabe, Sakura Hikida, Manabu Ikeda, et al.Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|March 5, 2024
Donepezil for dementia with Lewy bodies: meta-analysis of multicentre, randomised, double-blind, placebo-controlled phase II, III, and, IV studiesEtsuro Mori, Manabu Ikeda, Megumi OhdakeAnnals of Neurology|July 26, 2012
Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trialEtsuro Mori, Manabu Ikeda, Kenji Kosaka, et al.Alzheimer'S Research & Therapy|February 26, 2015
Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trialManabu Ikeda, Etsuro Mori, Kazutaka Matsuo, et al.Journal of Alzheimer'S Disease : JAD|July 24, 2023
Efficacy of Adjunctive Therapy with Zonisamide Versus Increased Dose of Levodopa for Motor Symptoms in Patients with Dementia with Lewy Bodies: The Randomized, Controlled, Non-Inferiority DUEL StudyManabu Ikeda, Etsuro Mori, Satoshi Orimo, et al.Dementia and Geriatric Cognitive Disorders|August 19, 2016
Pretreatment Cognitive Profile Likely to Benefit from Donepezil Treatment in Dementia with Lewy Bodies: Pooled Analyses of Two Randomized Controlled TrialsEtsuro Mori, Manabu Ikeda, Masaki Nakagawa, et al.Pageof 125